Total Payments
$59,003
2024 Payments
$8,258
Companies
65
Transactions
1,158
Medicare Patients
1,315
Medicare Billing
$207,244
Payment Breakdown by Category
Consulting$22,403 (38.0%)
Food & Beverage$22,039 (37.4%)
Other$8,685 (14.7%)
Travel$4,227 (7.2%)
Education$1,651 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $22,403 | 8 | 38.0% |
| Food and Beverage | $22,039 | 1,098 | 37.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,960 | 3 | 11.8% |
| Travel and Lodging | $4,227 | 16 | 7.2% |
| Honoraria | $1,725 | 1 | 2.9% |
| Education | $1,651 | 32 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $11,602 | 28 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $6,150 | 134 | $0 (2024) |
| Seattle Genetics, Inc. | $5,589 | 9 | $0 (2019) |
| Incyte Corporation | $5,483 | 118 | $0 (2024) |
| Exelixis Inc. | $4,628 | 73 | $0 (2024) |
| Gilead Sciences, Inc. | $3,793 | 40 | $0 (2024) |
| Janssen Biotech, Inc. | $3,722 | 103 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,756 | 61 | $0 (2024) |
| CTI BioPharma Corp. | $1,725 | 1 | $0 (2022) |
| Kite Pharma, Inc. | $1,700 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,258 | 173 | Incyte Corporation ($3,218) |
| 2023 | $8,285 | 155 | Gilead Sciences, Inc. ($3,354) |
| 2022 | $4,838 | 177 | CTI BioPharma Corp. ($1,725) |
| 2021 | $4,596 | 138 | Kite Pharma, Inc. ($1,700) |
| 2020 | $1,918 | 92 | Incyte Corporation ($406.41) |
| 2019 | $7,771 | 120 | Seattle Genetics, Inc. ($5,539) |
| 2018 | $13,482 | 156 | Takeda Pharmaceuticals U.S.A., Inc. ($11,072) |
| 2017 | $9,856 | 147 | Novartis Pharmaceuticals Corporation ($4,506) |
All Payment Transactions
1,158 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: BioOncology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $30.55 | General |
| Category: Hematology | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $28.03 | General |
| Category: Hematology/Oncology | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | — | Education | In-kind items and services | $13.30 | General |
| 12/11/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $7.06 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Oncology | ||||||
| 12/04/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/03/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: HORMONE THERAPY | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: BioOncology | ||||||
| 11/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.28 | General |
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $8.56 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $31.93 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Celgene Corporation | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $29.48 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $21.16 | General |
| Category: Hematology/Oncology | ||||||
| 11/04/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Oncology | ||||||
| 11/01/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $38.49 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 280 | 571 | $121,587 | $43,968 |
| 2022 | 8 | 310 | 753 | $138,494 | $47,955 |
| 2021 | 12 | 353 | 2,296 | $170,765 | $66,162 |
| 2020 | 11 | 372 | 1,109 | $132,369 | $49,159 |
Total Patients
1,315
Total Services
4,729
Medicare Billing
$207,244
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 162 | 326 | $89,716 | $32,083 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,764 | $2,575 | 38.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 15 | 24 | $6,576 | $2,523 | 38.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 17 | 31 | $6,051 | $2,361 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 33 | $6,442 | $2,074 | 32.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 12 | 25 | $3,675 | $1,351 | 36.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 22 | 76 | $1,216 | $578.36 | 47.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 37 | $1,147 | $423.97 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 172 | 351 | $99,500 | $34,600 | 34.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $12,889 | $4,509 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 30 | $6,054 | $1,996 | 33.0% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 11 | 69 | $4,833 | $1,791 | 37.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 16 | 26 | $5,224 | $1,673 | 32.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 13 | 35 | $5,610 | $1,558 | 27.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 24 | 140 | $2,240 | $1,075 | 48.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 67 | $2,144 | $751.76 | 35.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 144 | 292 | $83,676 | $32,320 | 38.6% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 14 | 101 | $34,611 | $13,706 | 39.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $11,469 | $4,517 | 39.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 21 | 34 | $9,773 | $3,628 | 37.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 14 | 48 | $8,160 | $3,114 | 38.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 40 | $8,108 | $3,057 | 37.7% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2021 | 17 | 79 | $5,758 | $2,313 | 40.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 18 | 169 | $5,368 | $2,151 | 40.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 31 | 157 | $2,512 | $1,220 | 48.6% |
About Dr. Sharon Yee, M.D
Dr. Sharon Yee, M.D is a Hospice and Palliative Medicine healthcare provider based in Arcadia, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215027560.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sharon Yee, M.D has received a total of $59,003 in payments from pharmaceutical and medical device companies, with $8,258 received in 2024. These payments were reported across 1,158 transactions from 65 companies. The most common payment nature is "Consulting Fee" ($22,403).
As a Medicare-enrolled provider, Yee has provided services to 1,315 Medicare beneficiaries, totaling 4,729 services with total Medicare billing of $207,244. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospice and Palliative Medicine
- Other Specialties Hematology & Oncology
- Location Arcadia, CA
- Active Since 10/14/2006
- Last Updated 12/13/2021
- Taxonomy Code 207RH0002X
- Entity Type Individual
- NPI Number 1215027560
Products in Payments
- NINLARO (Drug) $11,161
- ADCETRIS (Biological) $5,589
- Cabometyx (Drug) $3,818
- PDR001 (Drug) $3,700
- IMBRUVICA (Drug) $2,772
- JAKAFI (Drug) $1,930
- Vonjo (Drug) $1,725
- Tecartus (Drug) $1,700
- CALQUENCE (Drug) $1,537
- XTANDI (Drug) $1,112
- DARZALEX (Biological) $966.09
- CABOMETYX (Drug) $810.59
- LYNPARZA (Drug) $635.14
- Avastin (Biological) $546.78
- XPOVIO (Drug) $529.12
- GILOTRIF (Drug) $451.10
- Revlimid (Drug) $407.26
- SCEMBLIX (Drug) $337.66
- PROMACTA (Drug) $327.78
- ELITEK (Drug) $325.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.